Hybrid Lipid/Polymer Nanoparticles for Pulmonary Delivery of siRNA: Development and Fate Upon In Vitro Deposition on the Human Epithelial Airway Barrier
Author(s) -
Ivana d’Angelo,
Gabriella Costabile,
Estelle Durantie,
Paola Brocca,
Valeria Rondelli,
Annapina Russo,
Giulia Russo,
Agnese Miro,
Fabiana Quaglia,
Alke PetriFink,
Barbara RothenRutishauser,
Francesca Ungaro
Publication year - 2017
Publication title -
journal of aerosol medicine and pulmonary drug delivery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.678
H-Index - 68
eISSN - 1941-2703
pISSN - 1941-2711
DOI - 10.1089/jamp.2017.1364
Subject(s) - plga , biophysics , aerosolization , a549 cell , cytotoxicity , in vitro , chemistry , nanoparticle , materials science , nanotechnology , biochemistry , inhalation , biology , anatomy
Nowadays, the downregulation of genes involved in the pathogenesis of severe lung diseases through local siRNA delivery appears an interesting therapeutic approach. In this study, we propose novel hybrid lipid-polymer nanoparticles (hNPs) consisting of poly(lactic-co-glycolic) acid (PLGA) and dipalmitoyl phosphatidylcholine (DPPC) as siRNA inhalation system.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom